4//SEC Filing
Floyd Robert Michael 4
Accession 0001567619-23-000326
CIK 0001533743other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 5:43 PM ET
Size
10.5 KB
Accession
0001567619-23-000326
Insider Transaction Report
Form 4
Floyd Robert Michael
Chief Operating Officer
Transactions
- Award
Restricted Stock Units
2023-01-01+55,107→ 399,638 totalExercise: $0.00→ Common Stock (55,107 underlying) - Award
Restricted Stock Units
2022-12-31+10,851→ 344,531 totalExercise: $0.00→ Common Stock (10,851 underlying) - Award
Restricted Stock Units
2023-01-01+40,690→ 440,328 totalExercise: $0.00→ Common Stock (40,690 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment? the third anniversary of the award date? a change of control? or the reporting person's death. These restricted stock units vest on date of grant.
- [F2]Each restricted stock units represents a contingent right to receive one share of the lssuers common stock, following its vesting on 01/01/24, upon the earlier of termination of employment? the third anniversary of the award date? a change in control, or the reporting persons death,
- [F3]Each restricted stock units represents a contingent right to receive one share of the lssuers common stock, following its vesting of one-third on 01/01/24? 01/01/25 and 01/01/26, upon the earlier of termination of employment? the third anniversary of the award date? a change in control, or the reporting persons death.
Documents
Issuer
Processa Pharmaceuticals, Inc.
CIK 0001533743
Entity typeother
Related Parties
1- filerCIK 0001828217
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 5:43 PM ET
- Size
- 10.5 KB